Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro

Removal of Fe3+ and Zn2+ from plasma metalloproteins by iron chelating therapeutics depicted with SEC-ICP-AES

(2010) Melani Sooriyaarachchi et al.   DALTON TRANSACTIONS

Platinum Drug Distribution in Cancer Cells and Tumors

(2009) Alice V. Klein et al.   CHEMICAL REVIEWS

Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting

(2009) Katherine S. Lovejoy et al.   DALTON TRANSACTIONS

Analysis of the plasma metalloproteome by SEC–ICP-AES: bridging proteomics and metabolomics

(2009) Shawn A Manley et al.   Expert Review of Proteomics

Probing the interaction of arsenobetaine with blood plasma constituents in vitro: an SEC-ICP-AES study

(2009) Katie L. Pei et al.   Metallomics

Analytical methodologies for metallomics studies of antitumor Pt-containing drugs

(2009) Diego Esteban-Fernández et al.   Metallomics

Chemotherapy-associated renal dysfunction

(2009) Vaibhav Sahni et al.   Nature Reviews Nephrology

The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography???inductively coupled plasma mass spectrometry

(2008) Elke E.M. Brouwers et al.   ANTI-CANCER DRUGS

Atomic (HPLC-ICP-MS) and molecular mass spectrometry (ESI-Q-TOF) to study cis-platin interactions with serum proteins

(2008) Diego Esteban-Fernández et al.   JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY

Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by size-exclusion chromatography–inductively coupled plasma atomic emission spectroscopy

(2008) Shawn A. Manley et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Polymeric drug delivery of platinum-based anticancer agents

(2008) Katherine J. Haxton et al.   JOURNAL OF PHARMACEUTICAL SCIENCES